Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
26.02.24 | Berkshire bleibt auf Erfolgskurs | 304 | finanzjournalisten.de | Der Geschäftsbericht von Berkshire Hathaway wird jedes Frühjahr von mehr Anlegern erwartet als jeder andere. Denn neben den Unternehmenszahlen enthält er immer auch einen neuen der legendären "Briefe... ► Artikel lesen | |
26.02.24 | Barsele Minerals Corp.: Barsele and Gold Line Complete Previously Announced Merger | 450 | PR Newswire | VANCOUVER, BC AND TORONTO, Feb. 26, 2024 /CNW/ - Barsele Minerals Corp. ("Barsele") (TSXV: BME) and Gold Line Resources Ltd. ("Gold Line") (TSXV: GLDL) are pleased to announce, further to the news... ► Artikel lesen | |
26.02.24 | Open-Source-Projektmanagement-Software: Die 5 besten Tools | 427 | Capterra | Mit den richtigen Projektmanagement-Tools können Teams leichter ihre Ziele und Meilensteine erreichen, Fristen und Budgets einhalten und Projekte skalieren. In dieser Liste findest du die fünf am besten... ► Artikel lesen | |
26.02.24 | Abschluss des Verfahrens zur DFL-Zentralvermarktung: Bundeskartellamt billigt Vermarktungsmodell der DFL | 206 | Bundeskartellamt | Das Bundeskartellamt hat das Verfahren zur Prüfung des Vermarktungsmodells der Deutsche Fußball Liga (DFL) für die Vergabe der Medienrechte an den Spielen der Bundesliga und der 2. Bundesliga ab der... ► Artikel lesen | |
26.02.24 | APA Corporation Announces Timeline For Closing of Callon Petroleum Company Transaction; Issues Investor Slide Deck Highlighting Top-Tier Permian Performance | 235 | GlobeNewswire (Europe) | HOUSTON, Feb. 26, 2024 (GLOBE NEWSWIRE) -- APA Corporation (NASDAQ: APA) announced today that the applicable statutory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976... ► Artikel lesen | |
26.02.24 | Timbercreek Financial Announces 2023 Fourth Quarter Results and Special Dividend | 182 | GlobeNewswire (Europe) | TORONTO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Timbercreek Financial (TSX: TF) (the "Company") announced today its financial results for the three months and year ended December 31, 2023 ("Q4 2023").... ► Artikel lesen | |
26.02.24 | Carlyle Secured Lending, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results, Increases Base Dividend to $0.40 Per Common Share and Declares First Quarter 2024 Dividends of $0.48 Per Common Share | 295 | GlobeNewswire (Europe) | NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CSL" or the "Company") (NASDAQ: CGBD) today announced its... ► Artikel lesen | |
26.02.24 | Postal Realty Trust, Inc. Reports Fourth Quarter and Year End 2023 Results | 221 | GlobeNewswire (Europe) | - Acquired 75 USPS Properties for $20.7 Million in Fourth Quarter 2023 -- Net Income Attributable to Common Shareholders of $0.12 and Adjusted Funds from Operations of $1.07 Per Diluted Share for... ► Artikel lesen | |
26.02.24 | Scilex Holding Company's Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement | 196 | GlobeNewswire (Europe) | PALO ALTO, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, "Scilex" or "Company"), an innovative revenue-generating company focused on acquiring, developing and commercializing... ► Artikel lesen | |
26.02.24 | Rogers Sugar Inc.: Rogers Sugar Announces a $110 Million Equity Offering to Fund a Portion of its Sugar Capacity Expansion Project | 309 | GlobeNewswire (Europe) | MONTREAL, Feb. 26, 2024 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES Montreal (Québec), February 26, 2024 - Rogers Sugar Inc. (the "Company" or... ► Artikel lesen | |
26.02.24 | Day One Biopharmaceuticals, Inc.: Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress | 311 | GlobeNewswire (Europe) | PDUFA target action date for tovorafenib NDA in relapsed or progressive pLGG remains set for April 30, 2024 Phase 2 FIREFLY-1 tovorafenib registrational data published in Nature Medicine Ended 2023... ► Artikel lesen | |
26.02.24 | Dorman Products, Inc. Reports Fourth Quarter and Full Year 2023 Results; Issues 2024 Guidance | 339 | GlobeNewswire (Europe) | Highlights (All comparisons are to the prior year period unless otherwise noted): Net sales of $494.3 million for the quarter, down 1% reflecting the impact of an extra week in the prior year... ► Artikel lesen | |
26.02.24 | Kite Realty Group Trust Upgraded by Moody's to Baa2 with Stable Outlook | 252 | GlobeNewswire (Europe) | INDIANAPOLIS, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Kite Realty Group Trust (NYSE: KRG) announced today that Moody's Investors Service ("Moody's") upgraded the Company's corporate credit rating to Baa2... ► Artikel lesen | |
26.02.24 | Lithium Americas (Argentina) Corp.: Lithium Argentina Announces Appointment of new President and CEO | 367 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Lithium Americas (Argentina) Corp. (TSX: LAAC) (NYSE: LAAC) ("Lithium Argentina" or the "Company") announces the Board's unanimous decision... ► Artikel lesen | |
26.02.24 | Sezzle Fourth-Quarter and Fiscal Year 2023 Results | 182 | GlobeNewswire (Europe) | Minneapolis, MN, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, is pleased to provide the market with an update... ► Artikel lesen | |
26.02.24 | SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance | 229 | GlobeNewswire (Europe) | SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported... ► Artikel lesen | |
26.02.24 | FibroGen, Inc.: FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results | 537 | GlobeNewswire (Europe) | • Topline data from two pivotal pamrevlumab pancreatic cancer trials anticipated in 2Q 2024 • Additional data from Phase 1 monotherapy study of FG-3246 in metastatic castration-resistant prostate... ► Artikel lesen | |
26.02.24 | Revolution Medicines, Inc.: Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress | 235 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing targeted therapies for patients with RAS-addicted cancers... ► Artikel lesen | |
26.02.24 | PubMatic, Inc.: PubMatic Announces Record Fourth Quarter and Fiscal Year Ended 2023 Financial Results; Board of Directors Expands Share Repurchase Program by $100 Million | 261 | GlobeNewswire (Europe) | Q4 2023 revenue and adjusted EBITDA significantly exceeded guidance; Revenue growth accelerated to $84.6 million, up 14% over Q4 2022, delivered net income of $18.7 million or 22% margin, adjusted... ► Artikel lesen | |
26.02.24 | Codexis, Inc.: Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche | 346 | GlobeNewswire (Europe) | REDWOOD CITY, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an agreement with Roche for an exclusive... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 3.907 |
TESLA | 3.093 |
STEYR MOTORS | 2.787 |
DEUTZ | 2.700 |
RENK GROUP | 2.673 |
THYSSENKRUPP | 2.608 |
TUI | 2.277 |
NEL | 2.174 |
BYD | 2.126 |
RHEINMETALL | 2.111 |
BAYER | 1.516 |
XIAOMI | 1.456 |
NOVO NORDISK | 1.370 |
EVOTEC | 1.301 |
COMMERZBANK | 1.167 |
DEUTSCHE BANK | 1.149 |
BASF | 1.028 |
VOLKSWAGEN | 996 |
MERCEDES-BENZ | 972 |
AIXTRON SE | 969 |
MUTARES | 958 |
PUMA | 937 |
PORSCHE AG | 913 |
SUPER MICRO COMPUTER | 847 |
HENSOLDT | 835 |